ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SMTI vs INGN // EV/EBITDA & P/E VALUATION

Sanara MedTech Inc. (NASDAQ) VS. Inogen Inc (NASDAQ) • 15-METRIC TALLY: SMTI 10 — INGN 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SMTI VS. INGN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SMTI INGN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 92.70% 52.20% +40.50 SMTI /gross-margins <GO>
Return on Invested Capital (ROIC) 16.30% -27.00% +43.30 SMTI /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 29.5x — — TIE /valuation <GO>
Free Cash Flow Yield 0.71% -7.13% +7.84 SMTI /fcf-yield <GO>
Operating Margin 7.10% -10.20% +17.30 SMTI /operating-margins <GO>
Net Profit Margin 36.40% 7.70% +28.70 SMTI /net-margins <GO>
Revenue Growth (YoY) 19.00% 5.90% +13.10 SMTI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.25 1.46 +1.79 SMTI /balance-sheet <GO>
Piotroski F-Score Quality 7/9 4/9 +3.00 SMTI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 30.4 68.6 -38.20 INGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 6.8x 7.9x -1.10 SMTI /forward-pe <GO>
Enterprise Scale & Market Cap $302.4M $192.7M $109.8M SMTI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SMTI REV INGN REV SMTI GROSS % INGN GROSS % SMTI FCF INGN FCF
FY 2025 $103.1M $295.3M 92.7% 52.2% $2.2M -$13.7M
FY 2024 $86.7M $278.8M 90.6% 55.5% -$229.6K $2.6M
FY 2023 $65.0M $251.6M — — -$3.2M -$3.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SMTI // BETA —
INGN // BETA —